Our study provided the first demonstration that PCSK9 interacted with GSTP1, affected JNK phosphorylation levels, and inhibited HCC proliferation, which was highly important for further understanding the function of the PCSK9 protein and suggested that PCSK9 may be a therapeutic target for the treatment of HCC. Here, MAPK8 is linked to hepatocellular carcinoma.